Dana-Farber Cancer Institute
Postdoctoral Research Fellow - Hale Family Research Center
Dana-Farber Cancer Institute, Boston, Massachusetts, us, 02298
A Postdoctoral Research Fellow position
is available in the Singh group of the Hale Center of Pancreas Cancer Research at Dana-Farber Cancer Institute and Harvard Medical School which studies the genetics and biology of pancreatic cancer. The group is embedded within the labs of Drs. Andrew Aguirre and Brian Wolpin at Dana-Farber Cancer Institute. Research in the group is focused on highly translational studies of patient-derived specimens and the group works collaboratively within the Dana-Farber Hale Center for Pancreatic Cancer Research.Located in Boston and the surrounding communities, Dana-Farber Cancer Institute is a leader in life-changing breakthroughs in cancer research and patient care. We are united in our mission of conquering cancer, HIV/AIDS, and related diseases. We strive to create an inclusive, diverse, and equitable environment where we provide compassionate and comprehensive care to patients of all backgrounds.We are seeking a sincere and talented
postdoctoral researcher
to perform groundbreaking, hypothesis-driven research to study mechanisms of resistance to novel antibody drug conjugates and additional therapies in pancreatic cancer. Candidates with prior training and deep knowledge of molecular biology, preclinical drug testing, and translational medicine would be well suited for this position. The dynamic and rich environment of the Hale Center has extensive breadth of knowledge and expertise and will provide several exciting opportunities for collaboration and intellectual growth.We believe in the integration of molecular biology and omic approaches to understand pancreatic cancer with three major focus areas (MFA):MFA 1:
Understanding clinical implications of molecular features of pancreatic cancer in large patient cohorts.MFA 2:
Develop improved methods of monitoring and predicting response to therapy using circulating tumor DNA (ctDNA).MFA 3:
Basic mechanistic cancer biology with focus on preclinical studies using novel therapies for pancreatic cancer with emphasis on antibody drug conjugates and immunotherapies.Minimum Requirements:Ph.D., M.D., M.D./Ph.D., or doctoral equivalent in a relevant field (biology, immunology, cancer biology, or equivalent).Strong work ethic & highly collaborative interpersonal skillset.Proven ability to solve technical experimental problems.Ability to adapt research direction to changing data will be critical.A passion for learning and using innovative technological solutions to biologic problems is highly desired.At Dana-Farber Cancer Institute, we work every day to create an innovative, caring, and inclusive environment where every patient, family, and staff member feels they belong. As relentless as we are in our mission to reduce the burden of cancer for all, we are equally committed to diversifying our faculty and staff. If working in this kind of organization inspires you, we encourage you to apply.Dana-Farber Cancer Institute is an equal opportunity employer and affirms the right of every qualified applicant to receive consideration for employment without regard to race, color, religion, sex, gender identity or expression, national origin, sexual orientation, genetic information, disability, age, ancestry, military service, protected veteran status, or other characteristics protected by law.
#J-18808-Ljbffr
is available in the Singh group of the Hale Center of Pancreas Cancer Research at Dana-Farber Cancer Institute and Harvard Medical School which studies the genetics and biology of pancreatic cancer. The group is embedded within the labs of Drs. Andrew Aguirre and Brian Wolpin at Dana-Farber Cancer Institute. Research in the group is focused on highly translational studies of patient-derived specimens and the group works collaboratively within the Dana-Farber Hale Center for Pancreatic Cancer Research.Located in Boston and the surrounding communities, Dana-Farber Cancer Institute is a leader in life-changing breakthroughs in cancer research and patient care. We are united in our mission of conquering cancer, HIV/AIDS, and related diseases. We strive to create an inclusive, diverse, and equitable environment where we provide compassionate and comprehensive care to patients of all backgrounds.We are seeking a sincere and talented
postdoctoral researcher
to perform groundbreaking, hypothesis-driven research to study mechanisms of resistance to novel antibody drug conjugates and additional therapies in pancreatic cancer. Candidates with prior training and deep knowledge of molecular biology, preclinical drug testing, and translational medicine would be well suited for this position. The dynamic and rich environment of the Hale Center has extensive breadth of knowledge and expertise and will provide several exciting opportunities for collaboration and intellectual growth.We believe in the integration of molecular biology and omic approaches to understand pancreatic cancer with three major focus areas (MFA):MFA 1:
Understanding clinical implications of molecular features of pancreatic cancer in large patient cohorts.MFA 2:
Develop improved methods of monitoring and predicting response to therapy using circulating tumor DNA (ctDNA).MFA 3:
Basic mechanistic cancer biology with focus on preclinical studies using novel therapies for pancreatic cancer with emphasis on antibody drug conjugates and immunotherapies.Minimum Requirements:Ph.D., M.D., M.D./Ph.D., or doctoral equivalent in a relevant field (biology, immunology, cancer biology, or equivalent).Strong work ethic & highly collaborative interpersonal skillset.Proven ability to solve technical experimental problems.Ability to adapt research direction to changing data will be critical.A passion for learning and using innovative technological solutions to biologic problems is highly desired.At Dana-Farber Cancer Institute, we work every day to create an innovative, caring, and inclusive environment where every patient, family, and staff member feels they belong. As relentless as we are in our mission to reduce the burden of cancer for all, we are equally committed to diversifying our faculty and staff. If working in this kind of organization inspires you, we encourage you to apply.Dana-Farber Cancer Institute is an equal opportunity employer and affirms the right of every qualified applicant to receive consideration for employment without regard to race, color, religion, sex, gender identity or expression, national origin, sexual orientation, genetic information, disability, age, ancestry, military service, protected veteran status, or other characteristics protected by law.
#J-18808-Ljbffr